Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

Monday’s trading has closed, but SUPN is being traded in the after-hours session. After-Hours quote »
21.10
Delayed Data
As of 3:59pm ET
 -0.11 / -0.52%
Today’s Change
7.31
Today|||52-Week Range
22.07
+154.22%
Year-to-Date

Today’s Trading

Previous close21.21
Today’s open21.34
Day’s range20.62 - 22.07
Volume803,659
Average volume (3 months)1,155,104
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-51.56%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio29.9
Price/Sales3.44
Price/Book12.77

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+0.48+1.65%
ZFGNZafgen Inc+0.09+0.24%
ACHNAchillion Pharmaceut...-0.38-4.46%
DVAXDynavax Technologies...+0.80+2.72%
Data as of 3:59pm ET, 08/03/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)$0.02
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts